Eli Lilly's $1 Billion Lifeline: Transforming Telangana's Pharma Landscape
US pharmaceutical giant Eli Lilly is set to invest $1 billion in Telangana, enhancing its manufacturing and global medicine supply capacity. The decision was announced after meetings with Telangana officials. The expansion will include a new plant, creating significant employment opportunities for local youth.
- Country:
- India
US pharmaceutical giant Eli Lilly announced a substantial investment of $1 billion in Telangana to bolster its manufacturing and global medicine supply operations, the state government revealed on Monday.
The announcement followed discussions between Eli Lilly's global delegation and Telangana's Chief Minister A Revanth Reddy along with Industries Minister D Sridhar Babu at the Integrated Command Control Centre. An official release hailed this development as a major win for Telangana, emphasizing the boost to its pharma landscape.
The investment will pave the way for a new manufacturing plant and quality center, which promises to generate significant employment opportunities for the skilled youth of Telangana.
(With inputs from agencies.)
ALSO READ
Premier Energies to Lead Solar Manufacturing Revolution with Rs 11,000-Crore Expansion
Maruti Suzuki to Expand Gujarat Manufacturing with Rs 4,960-Crore Investment
Sankranti Surge: Heavy Traffic on Hyderabad-Vijayawada Highway
Manufacturing Malaise: U.S. Job Market's Stagnation Under Trump
Thrilling Victory: JSW Soorma Club Edges Out Hyderabad Toofans in HIL Shootout
Google News